Revive Ministries Inc is a licensed substance use treatment provider in Nicholasville, KY, listed in the SAMHSA treatment directory. Long term residential treatment is available for people who need more than a short stay. Outpatient care is offered, so clients can keep living at home between scheduled sessions. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientResidential/24-hour residentialOutpatient detoxificationOutpatient day treatment or partial hospitalizationOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentResidential detoxificationLong-term residentialShort-term residential
Type of care
Substance use treatmentDetoxificationTransitional housing, halfway house, or sober homeTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal, or any government funding for substance use treatment programsMedicaidPrivate health insuranceCash or self-payment
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyCommission on Accreditation of Rehabilitation Facilities (CARF)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
800 South Main Street, Suite C, Nicholasville, KY 40356
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid